Thomson Reuters Life Sciences Consulting
Thomson Reuters Life Sciences Consulting provides biopharmaceutical R&D productivity consulting services. We have evolved from and in collaboration with CMR International — the pharmaceutical industry's trusted partner in performance measurement, metrics, and benchmarking.
Serving the biopharmaceutical industry, industry associations and academic institutions, we sit within the Healthcare & Science division of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals.
We help our clients define, manage and mitigate their most pressing business challenges in R&D and clinical operations.
Why Work With Us?
Thomson Reuters Life Sciences Consulting has access to an unrivalled array of data sources, from the long-standing CMR International global R&D and Clinical performance metrics databases as well as Thomson Reuters Life Sciences portfolio such as Thomson Pharma® and Thomson Reuters IntegritySM. This allows us to provide quantitative data and insight driven consultancy services unavailable elsewhere.
Our team of highly qualified R&D consultants bring depth of industry knowledge and experience to our engagements. Proprietary internally developed methodologies, bespoke data visualization and analytics tools, and powerful modelling capabilities serve to set us apart.
The service we provide spans across the pharmaceutical R&D value chain from discovery to commercialization, with a particular focus on R&D productivity, including:
- R&D Decision Making (POC)
- R&D Investment Options
- R&D Pipeline Modelling
- R&D Portfolio Management
- R&D Return on Investment